Document:

Document

Exhibit 10.3

DermTech, Inc.

AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN

(As amended August 9, 2022)

The following constitute the provisions of the 2020 Employee Stock Purchase Plan (the "Plan") of DermTech, Inc. (the "Company").

1.Purpose.  The purpose of the Plan is to provide Employees of the Company and its Designated Subsidiaries with an opportunity to purchase Common Stock of the Company.  It is the intention of the Company to have the Plan qualify as an "Employee Stock Purchase Plan" under Section 423 of the Code.  The provisions of the Plan shall, accordingly, be construed so as to extend and limit participation in a manner consistent with the requirements of that section of the Code.

2.Definitions.

(a)"Board" shall mean the Board of Directors of the Company, or a committee of the Board of Directors named by the Board to administer the Plan.

(b)"Code" shall mean the Internal Revenue Code of 1986, as amended, including any successor statute, regulation and guidance thereto.

(c)"Common Stock" shall mean the common stock, $0.0001 par value per share, of the Company.

(d)"Company" shall mean DermTech, Inc., a Delaware corporation.

(e)"Compensation" shall mean the regular rate of salary or wages received by the Employee from the Company or a Designated Subsidiary that is taxable income for federal income tax purposes, including payments for overtime and shift premium, incentive compensation, incentive payments, bonuses and commissions, but excluding relocation, expense reimbursements, tuition or other reimbursements, other non-cash W-2 compensation (i.e. disqualifying dispositions, equity grants, equity exercises or settlements), or compensation received from the Company or a Designated Subsidiary. For purposes of determining a participant’s Compensation, any election by such participant to reduce his or her regular cash remuneration under Sections 125 (i.e. pre-tax cafeteria plan contributions) or 401(k) (i.e. pre-tax retirement contributions) of the Code (or in foreign jurisdictions, equivalent salary deductions) shall be treated as if the participant did not make such election and as if such reductions were not made. In other words ESPP Contributions are calculated on pre-tax Compensation but are withheld on a post-tax basis.  Pre-tax contributions, including but not limited to those under Section 125 and 401(k), are withheld first, and ESPP Contributions are withheld only if the remaining post-tax Compensation can satisfy the elected ESPP Contribution percentage.

(f)"Continuous Status as an Employee" shall mean the absence of any interruption or termination of service as an Employee.  Continuous Status as an Employee shall not be considered interrupted in the case of a leave of absence agreed to in writing by the Company, provided that such leave is for a period of not more than ninety (90) days or reemployment upon the expiration of such leave is guaranteed by contract or statute.

(g)"Contributions" shall mean all amounts credited to the account of a participant pursuant to the Plan.

(h)"Designated Subsidiaries" shall mean the Subsidiaries which have been designated by the Board from time to time in its sole discretion as eligible to participate in the Plan.

(i)"Employee" shall mean any person who is employed by the Company or one of its Designated Subsidiaries for tax purposes and who is customarily employed for at least twenty (20) hours per week and more than five (5) months in a calendar year by the Company or one of its Designated Subsidiaries.

(j)"Exercise Date" shall mean the last business day of each Offering Period or Purchase Period of the Plan.

(k)“Exercise Price” shall mean with respect to an Offering Period, an amount equal to 85% of the fair market value (as defined in Paragraph 7(b)) of a share of Common Stock on the Offering Date or on the Exercise Date, whichever is lower.

(l)"Offering Date" shall mean the first business day of each Offering Period of the Plan.

(m)"Offering Period" shall me an each twenty-four (24) month period commencing on each September 1 and March 1 to occur during the term of the Plan (or other such period or periods as determined by the Board in accordance with this Plan) with respect to which the right to purchase Common Stock may be granted under the Plan.

(n)"Plan" shall mean this DermTech, Inc. Employee Stock Purchase Plan.

(o)“Purchase Period” shall mean one or more periods within an Offering Period during which contributions may be made toward the purchase of Common Stock under the Plan, as determined by the Board. The Board shall have the power to change the duration of Purchase Periods.

(p)"Subsidiary" shall mean a corporation, domestic or foreign, of which not less than 50% of the voting shares are held by the Company or a Subsidiary, whether or not such corporation now exists or is hereafter organized or acquired by the Company or a Subsidiary.

3.Eligibility.

(a)Any person who has been continuously employed as an Employee for 1 month as of the Offering Date of a given Offering Period shall be eligible to participate in such Offering Period under the Plan and further, subject to the requirements of Paragraph 5(a) and the limitations imposed by Section 423(b) of the Code.  All Employees granted options under the Plan with respect to any Offering Period will have the same rights and privileges except for any differences that may be permitted pursuant to Section 423 of the Code.

(b)Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan if, immediately after the grant, such Employee (or any other person whose stock would be attributed to such Employee pursuant to Section 424(d) of the Code) would own stock and/or hold outstanding options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Subsidiary of the Company.  

(c)Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option to purchase Common Stock under the Plan with a fair market value as defined in Paragraph 7(b) 

(determined at the time such option is granted)  in excess of the following limit, which shall be applied in accordance with Section 423(b)(8) of the Code:

(i)In the case of Common Stock purchased during an Offering Period that commenced in the current calendar year, the limit shall be equal to (A) $25,000 minus (B) the Offering Date fair market value of the Common Stock that the Employee previously purchased in the current calendar year under this Plan and all other employee stock purchase plans (described in Section 423 of the Code) of the Company or any parent or Subsidiary of the Company;

(ii)In the case of Common Stock purchased during an Offering Period that commenced in the immediately preceding calendar year, the limit shall be equal to (A) $50,000 minus (B) the Offering Date fair market value of the Common Stock that the Employee previously purchased under this Plan and all other employee stock purchase plans (described in Section 423 of the Code) of the Company or any parent or Subsidiary of the Company in the current calendar year and in the immediately preceding calendar year;

(iii)In the case of Common Stock purchased during an Offering Period that commenced two calendar years prior, the limit shall be equal to (A) $75,000 minus (B) the Offering Date fair market value of the Common Stock that the Employee previously purchased under this Plan and all other employee stock purchase plans (described in Section 423 of the Code) of the Company or any parent or Subsidiary of the Company in the current calendar year and in the two immediately preceding calendar years.

(d)An Employee shall not be permitted to purchase more than 2,500 shares of Common Stock on an Exercise Date. The Board may, in its sole discretion, set a new maximum number of shares that may be purchased by any participant on an Exercise Date. If a lower limit is set under this Paragraph 3(d), the Board shall notify participants of such limit prior to the commencement of the next Purchase Period for which it is to be effective.

(e)If the number of shares to be purchased on an Exercise Date by all Employees participating in this Plan exceeds the number of shares then available for issuance under this Plan, then the Company will make a pro rata allocation of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Board shall determine to be equitable. In such event, the Company shall give written notice of such reduction of the number of shares to be purchased under a participant’s option to each participant affected.

(f)Any payroll deductions accumulated in an Employee’s account which are not used to purchase Common Stock due to the limitations in this Paragraph 3 shall be returned to the participant as soon as practicable after the end of the applicable Purchase Period, without interest (except to the extent required due to local legal requirements outside the United States).

(g)If a participant is precluded by the limitations of this Paragraph 3 from purchasing additional Common Stock under the Plan, then his or her employee contributions may be automatically discontinued by the Company and shall automatically resume at the beginning of the earliest Purchase Period that will end in the next calendar year (if he or she then is an eligible Employee), provided that when the Company automatically resumes such payroll deductions, the Company must apply the rate in effect immediately prior to such suspension.

(h)Any option granted under the Plan shall be deemed to be modified to the extent necessary to satisfy this Paragraph 3.

4.Offering Periods.

(a)The Plan shall be implemented by a series of Offering Periods, with a new Offering Period commencing on September 1 and March 1 of each year or the first business day thereafter (or at such other time or times as may be determined by the Board). Each Offering Period shall consist of four (4) six-month Purchase Periods commencing on each September 1 and March 1 to occur during the Offering Period or the first business day thereafter and ending February 28 (or the 29th if February has 29 days) and August 31 of each year (or commencing and ending at other such time or times as may be determined by the Board), during which payroll deductions of the participants are accumulated under this Plan. The Board shall have the power to change the Offering Dates, the Exercise Dates, and the duration of Offering Periods (provided that an Offering Period will in no event be longer than twenty-seven (27) months) or Purchase Periods without stockholder approval if such change is announced prior to the relevant Offering Period or prior to such other time period as specified by the Board.  The initial Offering Period shall commence on September 1, 2020. 

(b)If the fair market value of a share of Common Stock on any Exercise Date that occurs during an Offering Period is less than the fair market value of a share of Common Stock on the Offering Date of the applicable Offering Period, then such Offering Period shall automatically terminate immediately after the purchase of shares of Common Stock on such Exercise Date and a new subsequent Offering Period shall commence on the September 1 or March 1 next following such Exercise Date (or the first business day thereafter or such other time as may be determined by the Board) (an “Automatic Reset”). 

5.Participation.

(a)An eligible Employee may become a participant in the Plan by completing an Enrollment Form provided by the Company and filing it with the Company or its designee at least seven (7) days prior to the applicable Offering Date, unless a later time for filing the Enrollment Form is set by the Board for all eligible Employees with respect to a given Offering Period and provided, however, that upon the termination of an Offering Period as a result of an Automatic Reset, each participant in such Offering Period shall automatically participate in the immediately following Offering Period on the same terms on which the participant participated in the terminated Offering Period pursuant to the participant’s existing Enrollment Form (as may be subsequently modified or revoked in accordance with the Plan).  The Enrollment Form and its submission may be electronic as directed by the Company.  The Enrollment Form shall set forth the percentage of the participant's Compensation (which shall be not less than one percent (1%) and not more than fifteen percent (15%), in increments not less than one percent (1%), to be paid as Contributions pursuant to the Plan.

(b)Payroll deductions shall commence with the first payroll or as soon as practicable following the Offering Date, unless a later time is set by the Board with respect to a given Offering Period, and shall end on the last payroll paid on or prior to the Exercise Date of the Offering Period to which the Enrollment Form is applicable, unless sooner terminated as provided in Paragraph 10.

6.Method of Payment of Contributions.

(a)Each participant shall elect to have payroll deductions made on each payroll during the Offering Period in an amount not less than one percent (1%) and not more than fifteen percent (15%), in increments not less than one percent (1%), of such participant's Compensation on each such payroll (or such other percentage as the Board may establish from time to time before an Offering Date).  All payroll 

deductions made by a participant shall be credited to his or her account under the Plan.  A participant may not make any additional payments into such account.

(b)A participant may discontinue his or her participation in the Plan as provided in Paragraph 10, or, on one occasion only during the Purchase Period, may decrease, but may not increase, the rate of his or her Contributions during the Offering Period by completing and filing with the Company a new Enrollment Form authorizing a change in the deduction rate.  The change in rate shall be effective as of the beginning of the next payroll period or as soon as practicable following the date of filing of the new Enrollment Form, if the Enrollment Form is submitted at least seven (7) days prior to such date, and, if not, as of the beginning of the next succeeding payroll period. A reduction of the payroll deduction percentage to zero shall be treated as participant’s withdrawal from such Offering Period and the Plan, effective as of the day after the next Purchase Date following the filing date of such request with the Company.

(c)Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Paragraph 3, a participant’s payroll deductions may be suspended at any time during any Offering Period.

7.Grant of Option.

(a)On the Offering Date of each Offering Period, each eligible Employee participating in such Offering Period shall be granted an option to purchase on each Exercise Date of such Offering Period a number of shares of the Common Stock determined by dividing such Employee's Contributions accumulated prior to such Exercise Date and retained in the participant's account as of the Exercise Date by the applicable Exercise Price; provided however, that such purchase shall be subject to the limitations set forth in Paragraphs 3 and 12.  The fair market value of a share of the Common Stock shall be determined as provided in Paragraph 7(b).

(b)The fair market value of the Common Stock on a given date shall be (i) if the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or last sale price of the Common Stock for such date (or, in the event that the Common Stock is not traded on such date, on the immediately preceding trading date), on the composite tape or other comparable reporting system; or (ii) if the Common Stock is not listed on a national securities exchange and such price is not regularly reported, the mean between the bid and asked prices per share of the Common Stock at the close of trading in the over-the-counter market.  

8.Exercise of Option.  Unless a participant withdraws from the Plan as provided in Paragraph 10, his or her option for the purchase of shares will be exercised automatically on each Exercise Date, and the maximum number of full shares subject to the option will be purchased for him or her at the applicable Exercise Price with the accumulated Contributions in his or her account.  If a fractional number of shares results, then such number shall be rounded down to the next whole number and any unapplied cash shall be carried forward to the next Exercise Date, unless the participant requests a cash payment.  The shares purchased upon exercise of an option hereunder shall be deemed to be transferred to the participant on the Exercise Date.  During a participant's lifetime, a participant's option to purchase shares hereunder is exercisable only by him or her.

9.Delivery.  Upon the written request of a participant, certificates representing the shares purchased upon exercise of an option will be issued as promptly as practicable after the applicable Exercise Date to participants who wish to hold their shares in certificate form, except that the Board may determine that such shares shall be held for each participant's benefit by a broker designated by the Board.  Any payroll deductions accumulated in a participant’s account which are not sufficient to purchase a full 

Share shall be retained in the participant’s account for the subsequent Offering Period, subject to earlier withdrawal by the participant as provided in Paragraph 10 below.  Any other amounts left over in a participant’s account after an Exercise Date shall be returned to the participant.

10.Withdrawal; Termination of Employment.

(a)A participant may withdraw all but not less than all the Contributions credited to his or her account under the Plan at any time prior to an Exercise Date by giving written notice, or electronic submission of withdrawal, to the Company or its designee no later than 3 business days prior to each Exercise Date.  All of the participant's Contributions credited to his or her account will be paid to him or her promptly after receipt of his or her notice of withdrawal and his or her option for the current period will be automatically terminated, and no further Contributions for the purchase of shares will be made during the Offering Period.

(b)Upon termination of the participant's Continuous Status as an Employee prior to an Exercise Date for any reason, including retirement or death, the Contributions credited to his or her account will be returned to him or her or, in the case of his or her death, to the person or persons entitled thereto under Paragraph 14, and his or her option will be automatically terminated.

(c)In the event an Employee fails to remain in Continuous Status as an Employee for at least 20 hours per week during the Offering Period in which the Employee is a participant, he or she will be deemed to have elected to withdraw from the Plan and the Contributions credited to his or her account will be returned to him or her and his or her option terminated.

(d)A participant's withdrawal from an Offering Period will not have any effect upon his or her eligibility to participate in a succeeding offering or in any similar plan which may hereafter be adopted by the Company.

11.Interest.  No interest shall accrue on the Contributions of a participant in the Plan.

12.Stock.

(a)The maximum number of shares of Common Stock which shall be made available for sale under the Plan shall be 400,000 shares, plus an annual increase on the first day of each of the Company’s fiscal years beginning in 2021 and ending on the first day of 2030, equal to the lesser of (i) 300,000 shares, (ii) one percent (1%) of the shares of Common Stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as is determined by the Board, subject to adjustment upon changes in capitalization of the Company as provided in Paragraph 18.  If the total number of shares which would otherwise be subject to options granted pursuant to Paragraph 7(a) on the Offering Date of an Offering Period exceeds the number of shares then available under the Plan (after deduction of all shares for which options have been exercised), the Company shall make a pro rata allocation of the shares remaining available for option grants in as uniform a manner as shall be practicable and as it shall determine to be equitable.  Any amounts remaining in an Employee's account not applied to the purchase of shares pursuant to this Paragraph 12 shall be refunded on or promptly after the Exercise Date.  In such event, the Company shall give written notice of such reduction of the number of shares subject to the option to each Employee affected thereby and shall similarly reduce the rate of Contributions, if necessary.

(b)The participant will have no interest or voting right in shares covered by his or her option until such option has been exercised.

13.Administration.  The Board shall supervise and administer the Plan and shall have full power to adopt, amend and rescind any rules deemed desirable and appropriate for the administration of the Plan and not inconsistent with the Plan, to construe and interpret the Plan, to correct any defect or supply any omission or reconcile any inconsistency or ambiguity in the Plan and to make all other determinations necessary or advisable for the administration of the Plan, including without limitation, adopting subplans applicable to particular Designated Subsidiaries or locations, which subplans may be designed to be outside the scope of Section 423 of the Code.

14.Designation of Beneficiary.

(a)A participant may designate a beneficiary who is to receive any shares and cash, if any, from the participant's account under the Plan in the event of such participant's death subsequent to the end of the Purchase Period but prior to delivery to him or her of such shares and cash.  In addition, a participant may designate a beneficiary who is to receive any cash from the participant's account under the Plan in the event of such participant's death prior to each Exercise Date of the Offering Period.  If a participant is married and the designated beneficiary is not the spouse, spousal consent shall be required for such designation to be effective.  Beneficiary designations shall be made either in writing or by electronic delivery as directed by the Company.

(b)Such designation of beneficiary may be changed by the participant (and his or her spouse, if any) at any time by submission of the required notice, which may be electronic.  In the event of the death of a participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant's death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of the participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or relatives of the participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.

15.Transferability.  Neither Contributions credited to a participant's account nor any rights with regard to the exercise of an option or to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Paragraph 14) by the participant.  Any such attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds in accordance with Paragraph 10.

16.Use of Funds.  All Contributions received or held by the Company under the Plan may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such Contributions.

17.Reports.  Individual accounts will be maintained for each participant in the Plan.  Statements of account will be provided to participating Employees promptly following the Exercise Date, which statements will set forth the amounts of Contributions, the per share purchase price, the number of shares purchased and the remaining cash balance, if any.

18.Adjustments upon Changes in Capitalization.  Subject to any required action by the stockholders of the Company, the number of shares of Common Stock covered by unexercised options under the Plan, the number of shares of Common Stock which have been authorized for issuance under the Plan but are not yet subject to options under Paragraph 12(a) and the number of shares of Common Stock subject to annual increase under Paragraph 12(a) (collectively, the "Reserves"), the maximum number of shares of Common Stock that may be purchased by a participant in an Offering Period set forth in Paragraph 3 as well as the price per share of Common Stock covered by each unexercised option under the Plan, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock. Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive.  

In the event of the proposed dissolution or liquidation of the Company, an Offering Period then in progress will terminate immediately prior to the consummation of such proposed action, unless otherwise provided by the Board.  In the event of a proposed sale of all or substantially all of the assets of the Company, or the merger, consolidation or other capital reorganization of the Company with or into another corporation, each option outstanding under the Plan shall be assumed or an equivalent option shall be substituted by such successor corporation or a parent or subsidiary of such successor corporation, unless the Board determines, in the exercise of its sole discretion and in lieu of such assumption or substitution, to shorten the Offering Period then in progress by setting a new Exercise Date (the "New Exercise Date").  If the Board shortens the Offering Period then in progress in lieu of assumption or substitution in the event of a merger or sale of assets, the Board shall notify each participant in writing, at least ten days prior to the New Exercise Date, that the Exercise Date for his or her option has been changed to the New Exercise Date and that his or her option will be exercised automatically on the New Exercise Date, unless prior to such date he or she has withdrawn from the Offering Period as provided in Paragraph 10.  For purposes of this paragraph, an option granted under the Plan shall be deemed to be assumed if, following the sale of assets, merger or other reorganization, the option confers the right to purchase, for each share of Common Stock subject to the option immediately prior to the sale of assets, merger or other reorganization, the consideration (whether stock, cash or other securities or property) received in the sale of assets, merger or other reorganization by holders of Common Stock for each share of Common Stock held on the effective date of such transaction (and if such holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if such consideration received in such transaction was not solely common stock of the successor corporation or its parent (as defined in Section 424(e) of the Code), the Board may, with the consent of the successor corporation, provide for the consideration to be received upon exercise of the option to be solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of Common Stock in the sale of assets, merger or other reorganization.

The Board may, if it so determines in the exercise of its sole discretion, also make provision for adjusting the Reserves, as well as the price per share of Common Stock covered by each outstanding option, in the event that the Company effects one or more reorganizations, recapitalizations, rights offerings or other increases or reductions of shares of its outstanding Common Stock, and in the event of the Company being consolidated with or merged into any other corporation.

19.Amendment or Termination.

(a)The Board may at any time terminate or amend the Plan.  Except as provided in Paragraph 18, no such termination may affect options previously granted, nor may an amendment make any change in any option theretofore granted which adversely affects the rights of any participant provided that an Offering Period may be terminated by the Board on an Exercise Date or by the Board’s setting a new Exercise Date with respect to an Offering Period then in progress if the Board determines that termination of the Offering Period is in the best interests of the Company and the stockholders or if continuation of the Offering Period would cause the Company to incur adverse accounting charges in the generally-accepted accounting rules applicable to the Plan.  In addition, to the extent necessary to comply with Section 423 of the Code (or any successor rule or provision or any applicable law or regulation), the Company shall obtain stockholder approval in such a manner and to such a degree as so required.

(b)Without stockholder consent and without regard to whether any participant rights may be considered to have been adversely affected, the Board shall be entitled to change the Offering Periods, limit the frequency and/or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each participant properly correspond with amounts withheld from the participant’s Compensation, and establish such other limitations or procedures as the Board determines in its sole discretion advisable that are consistent with the Plan.

20.Notices.  All notices or other communications by a participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.

21.Conditions upon Issuance of Shares.  Shares shall not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance.

As a condition to the exercise of an option, the Company may require the person exercising such option to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned applicable provisions of law.

22.Information Regarding Disqualifying Dispositions.  By electing to participate in the Plan, each participant agrees to provide any information about any transfer of shares of Common Stock acquired under the Plan that occurs within two years after the first business day of the Offering Period in which such shares were acquired as may be requested by the Company or any Subsidiaries in order to assist it in complying with the tax laws.

23.Right to Terminate Employment.  Nothing in the Plan or in any agreement entered into pursuant to the Plan shall confer upon any Employee the right to continue in the employment of the Company or any Subsidiary, or affect any right which the Company or any Subsidiary may have to terminate the employment of such Employee.

24.Rights as a Stockholder.  Neither the granting of an option nor a deduction from payroll shall constitute an Employee the owner of shares covered by an option.  No Employee shall have any right as a stockholder unless and until an option has been exercised, and the shares underlying the option have been registered in the Company's share register.

25.Term of Plan.  The Plan became effective upon its approval on May 26, 2020 and shall continue in effect through the tenth anniversary of such date, unless sooner terminated under Paragraph 19.

26.Applicable Law.  This Plan shall be governed in accordance with the laws of the State of Delaware, applied without giving effect to any conflict-of-law principles.EX-10.1

 Exhibit 10.1 

FORM OF INVESTOR SUPPORT AGREEMENT 

THIS INVESTOR SUPPORT AGREEMENT (this “Agreement”) is dated as of [_________], 2022 by and among Periphas Capital Partnering
Corporation, a Delaware corporation (“PCPC”), and the shareholder of PCPC whose name appears on the signature page of this Agreement (the “Investor”). 

RECITALS 
 WHEREAS,
PCPC was formed for the purpose of identifying a company to partner with, in order to effectuate a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses
(“Partnering Transaction”); 
 WHEREAS, PCPC’s certificate of incorporation provides that in the event that
PCPC has not consummated an initial Partnering Transaction within 24 months (or 27 months if PCPC has executed a letter of intent, agreement in principle or definitive agreement for an initial Partnering Transaction within 24 months) of
December 14, 2020 (the “Termination Date”) or such later date as approved by holders of a majority of the voting power of PCPC’s then outstanding common stock that are voted at a meeting to extend such date, voting
together as a single class, PCPC shall (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor,
redeem 100% of the public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of permitted withdrawals), divided by
the number of then outstanding public shares, subject to applicable law and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors in accordance with
applicable law, dissolve and liquidate. 
 WHEREAS, PCPC is pursuing a potential Partnering Transaction and desires to submit to a
vote of its stockholders a proposal (the “Extension Proposal”) to extend the date by which PCPC must consummate a Partnering Transaction from the Termination Date to September 30, 2023 or such earlier date as determined by the
board of directors of PCPC (the “Extension”); 
 WHEREAS, as of the date hereof, the Investor beneficially owns (as
defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), and has sole voting power with respect to the number of shares of Class A common
stock, par value $0.0001 per share, of PCPC (the “PCPC Shares”), and owns the number of warrants (“PCPC Warrants”) exercisable for PCPC Shares, as indicated on the signature page hereto; 

WHEREAS, as an inducement to PCPC to seek the Extension, the parties hereto desire to agree to certain matters as set forth herein.

 NOW, THEREFORE, in consideration of the foregoing and the mutual agreements contained herein, and intending to be legally bound
hereby, the parties hereto hereby agree as follows: 
  

 ARTICLE I 

COVENANTS 

Section 1.1 Agreement to Vote. The Investor hereby agrees to appear and vote at any duly called meeting of the shareholders of
PCPC (or any adjournment or postponement thereof), provide his, her or its written consent in any action by written resolution of the shareholders of PCPC, or in any other circumstance in which the vote, consent or other approval of the shareholders
of PCPC is sought, all of such PCPC Shares, and in each case cause all the PCPC Shares held by the Investor to be counted as present thereat for purposes of calculating a quorum, and vote or provide his, her or its consent: (a) in favor of the
Extension Proposal, (b) in favor of any other matter reasonably necessary or required to the effect the Extension and considered and voted upon by the shareholders of PCPC and (c) against any proposal that conflicts or materially impedes
or interferes with, or would adversely affect or delay the approval of, the Extension Proposal. Notwithstanding the foregoing, PCPC hereby acknowledges that the Investor has agreed to the covenants in this Section 1.1 only on the assumption
that PCPC will consummate a Partnering Transaction with a particular target, and PCPC further acknowledges that if a Partnering Transaction is not consummated with such target, then it is the present intention of the Investor (but it being
understood that the Investor is not hereby bound) to redeem all of the Investor’s PCPC Shares (provided that such redemption right is available) or otherwise not consent to or participate in any other transaction which may be effected by PCPC.

 Section 1.2 No Redemption. The Investor hereby agrees, for the benefit of PCPC, not to redeem, submit a request to
PCPC’s transfer agent to redeem, or otherwise exercise any right to redeem any PCPC Shares, and to reverse and revoke any prior redemption elections made with respect to the PCPC Shares, in each case solely in connection with the vote of the
holders of the PCPC shares to approve the Extension Proposal and the effectiveness of the Extension. For the avoidance of doubt, nothing in this Section 1.2 or in any other provision of this Agreement shall limit or otherwise restrict the
ability of the Investor to redeem or request the redemption of any PCPC Shares (provided that such redemption right is available), other than in connection with a stockholder vote on the Extension Proposal and the effectiveness of the Extension as
set forth in this Section 1.2. 
 Section 1.3 No Transfer. During the period commencing on the date hereof and ending on
the earlier of (a) December 14, 2022 or (b) the date of PCPC’s determination to abandon the Extension Proposal prior to the stockholder vote on the Extension Proposal, the Investor shall not (i) sell, offer to sell, contract
or agree to sell (including, without limitation, sell short), assign, hypothecate, pledge, create a mortgage, pledge, security interest, encumbrance, lien, license or sub-license, depository receipt issued for
shares with meeting rights, attachment, charge, or other similar encumbrance or interest (including voting, transfer or similar restrictions) (a “Lien”) on, grant any option to purchase, transfer, or otherwise dispose of or agree to
dispose of, directly or indirectly, file (or participate in the filing of) a registration statement with the Securities and Exchange Commission, deposit into a voting trust, grant any proxy or power of attorney with respect to, or establish or
increase a put equivalent position or liquidate or decrease a call equivalent position (within the meaning of Section 16 of the Exchange Act) with respect to, any PCPC Shares or PCPC Warrants held by the Investor, (ii) enter into any swap
or other arrangement that transfers to another individual, partnership, corporation, limited liability 

  
 2 

 
company, joint stock company, unincorporated organization or association, trust, joint venture, foundation or other similar entity, whether or not a legal entity (a “Person”), in
whole or in part, any of the economic consequences of ownership of any PCPC Shares or PCPC Warrants held by the Investor (clauses (i) and (ii) collectively, a “Transfer”) or (iii) publicly announce any intention to effect
any transaction specified in clause (i) or (ii); provided, however, that the foregoing shall not prohibit Transfers from the Investor to any other Person who directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such Investor (an “Affiliate”), so long as, prior to and as a condition to the effectiveness of any such Transfer, such Affiliate executes and delivers to PCPC a joinder to this
Agreement in the form attached hereto as Annex A. 
 Section 1.4 New Shares. In the event that (a) any PCPC Shares,
PCPC Warrants or other capital stock of PCPC are issued to the Investor or any of its Affiliates after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination, conversion or exchange of
PCPC Shares or PCPC Warrants of, on or affecting the PCPC Shares or PCPC Warrants owned by the Investor or otherwise, (b) the Investor purchases or otherwise acquires beneficial ownership of any PCPC Shares, PCPC Warrants or other capital stock
of PCPC after the date of this Agreement, or (c) the Investor acquires the right to vote or share in the voting of any PCPC Shares or other capital stock of PCPC after the date of this Agreement (such PCPC Shares, PCPC Warrants or other capital
stock issued, purchased or acquired as described in any of the foregoing clauses (a) through (c), collectively, the “New Securities”), then (x) the Investor shall notify PCPC in writing and as promptly as reasonably
practicable of any such New Securities and (y) such New Securities shall be subject to the terms of this Agreement to the same extent as if they constituted the PCPC Shares or PCPC Warrants owned by the Investor as of the date hereof. 

ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Section 2.1 Representations and Warranties of the Investor. The Investor represents and warrants as of the date hereof to
PCPC as follows: 
 (a) Organization; Due Authorization. The Investor has the full power and authority to execute and deliver this
Agreement and to perform the Investor’s obligations hereunder. If the Investor is an entity, it is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, formed, organized or
constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby are within such Investor’s corporate, limited liability company or organizational powers and have been duly
authorized by all necessary corporate, limited liability company or organizational actions on the part of such Investor. This Agreement has been duly executed and delivered by the Investor and, assuming due authorization, execution and delivery by
the other parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of the Investor, enforceable against the Investor in accordance with the terms hereof (subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity). If this Agreement is being executed in a representative or fiduciary capacity, the Person signing
this Agreement has full power and authority to enter into this Agreement on behalf of the Investor. 

  
 3 

 (b) Ownership. The Investor is the record and beneficial owner (as defined in the
Exchange Act) of, and has good title to the PCPC Shares and PCPC Warrants set forth on the signature page hereto, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise
dispose of such PCPC Shares or PCPC Warrants (other than transfer restrictions under the Securities Act of 1933, as amended) affecting any such PCPC Shares or PCPC Warrants, other than Liens pursuant to (i) this Agreement, (ii) PCPC’s
certificate of incorporation or bylaws, or (iii) any applicable securities law. The PCPC Shares and PCPC Warrants set forth on the signature page hereto are the only capital stock in PCPC owned of record or beneficially by the Investor on the
date of this Agreement, and none of the Investor’s PCPC Shares or PCPC Warrants are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such PCPC Shares or PCPC Warrants, except as provided
hereunder. Other than the PCPC Warrants, the Investor does not hold or own any rights to acquire (directly or indirectly) any capital stock of PCPC or any securities convertible into, or which can be exchanged for, capital stock of PCPC. 

(c) No Conflicts. The execution and delivery of this Agreement by the Investor does not, and the performance by the Investor of its
obligations hereunder will not, (i) conflict with or result in a violation of the organizational documents of the Investor or (ii) require any consent or approval that has not been given or other action that has not been taken by any
Person (including under any written or oral agreement, contract, license, lease, obligation, undertaking or other commitment or arrangement that is legally binding upon the Investor or any of his, her or its properties or assets or the
Investor’s PCPC Shares or PCPC Warrants), in each case, to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by the Investor of its, his or her obligations under this Agreement, or the
transactions contemplated hereby. 
 (d) Litigation. There are no actions, suits or proceedings by or before any court or
governmental agency, authority or body or any arbitrator (“Proceedings”) pending against the Investor, or, to the knowledge of the Investor, threatened against the Investor, which in any manner challenges or seeks to prevent, enjoin
or materially delay the performance by the Investor of its, his or her obligations under this Agreement or the transactions contemplated hereby. 

(e) No Brokers. No investment banker, broker, finder, consultant or intermediary or other Person is entitled to any broker’s,
finder’s, financial advisor’s or other similar fee or commission based upon arrangements made by or on behalf of the Investor in connection with its entering into this Agreement. 

  
 4 

 (f) Acknowledgments. The Investor understands and acknowledges that PCPC is intending
to seek the Extension in reliance upon the Investor’s execution and delivery of this Agreement. The Investor understands and further acknowledges that the date of automatic termination pursuant to Section 7(b)(ii) of that certain Forward
Purchase Agreement, dated December 9, 2020, between PCPC and the Investor will be extended to September 30, 2023 upon the requisite approval by the holders of the PCPC Shares of such Extension Proposal. 

(g) No Other Representations or Warranties. Except for the representations and warranties made by the Investor in this Article
II, neither the Investor nor any other Person makes any express or implied representation or warranty to PCPC or PCPC Holdings, LLC (“Sponsor”) in connection with this Agreement or the transactions contemplated by this
Agreement, and the Investor expressly disclaims any such other representations or warranties. 
 ARTICLE III 

MISCELLANEOUS 

Section 3.1 Termination. This Agreement and all of its provisions shall terminate and be of no further force or effect upon the
earlier of: (a) September 30, 2023, (b) PCPC’s determination to abandon the Extension Proposal prior to the stockholder vote on the Extension Proposal, (c) the liquidation of PCPC and (d) the written agreement of the
Investor and PCPC. Upon such termination of this Agreement, all obligations of the parties under this Agreement will terminate, without any liability or other obligation on the part of any party hereto to any Person in respect hereof or the
transactions contemplated hereby, and no party hereto shall have any claim against another (and no Person shall have any rights against such party), whether under contract, tort or otherwise, with respect to the subject matter hereof;
provided, however, that the termination of this Agreement shall not relieve any party hereto from liability arising in respect of any breach of this Agreement prior to such termination. This Article III shall survive the
termination of this Agreement. 
 Section 3.2 Governing Law; Venue. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the law of any
jurisdiction other than the State of Delaware. Each of the parties irrevocably and unconditionally submits to the exclusive jurisdiction of the Chancery Court of the State of Delaware (or, if the Chancery Court of the State of Delaware declines to
accept jurisdiction, any state or federal court within the State of Delaware or, in the event each federal court within the State of Delaware declines to accept jurisdiction, any other Delaware state court), for the purposes of any Proceeding
(a) arising under this Agreement or (b) in any way connected with or related or incidental to the dealings of the parties in respect of this Agreement, and irrevocably and unconditionally waives any objection to the laying of venue of any
such Proceeding in any such court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such Proceeding has been brought in an inconvenient forum. Each party irrevocably and unconditionally
waives, and agrees not to assert, by way of motion or as a defense, counterclaim 

  
 5 

 
or otherwise, in any Proceeding against such party (i) arising under this Agreement or (ii) in any way connected with or related or incidental to the dealings of the parties in respect
of this Agreement, (A) any claim that it is not personally subject to the jurisdiction of the courts as described in this Section 3.2 for any reason, (B) that it or its property is exempt or immune from the
jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (C) that
(1) the Proceeding in any such court is brought against such party in an inconvenient forum, (2) the venue of such Proceeding against such party is improper or (3) this Agreement, or the subject matter hereof, may not be enforced
against such party in or by such courts. Each Party agrees that service of any process, summons, notice or document by registered mail to such party’s respective address set forth in Section 3.8 below shall be
effective service of process for any such Proceeding. 
 Section 3.3 Waiver of Jury Trial. THE PARTIES EACH HEREBY WAIVES, TO
THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING,
AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. THE PARTIES EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL
COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY
OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER,
(C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY AND (D) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 3.3. 

Section 3.4 Assignment. This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the
parties hereto and their respective heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder will be assigned (including by operation of law) without the prior written consent of all
of the other parties hereto. 
 Section 3.5 Specific Performance. The parties hereto agree that irreparable damage may occur in
the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled to an injunction or injunctions to
prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the Chancery Court of the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction, any state
or federal court within the State of Delaware or, in the 

  
 6 

 
event each federal court within the State of Delaware declines to accept jurisdiction, any other Delaware state court), this being in addition to any other remedy to which such party is entitled
at law or in equity, and in each case, without posting a bond or undertaking and without proof of damages. Each of the parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief when
expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. 

Section 3.6 Amendment. This Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated,
except upon the execution and delivery of a written agreement executed by PCPC and the Investor. Notwithstanding anything to the contrary contained herein, any holder of PCPC Shares or PCPC Warrants may become party to this Agreement by executing
and delivering a joinder to this Agreement in the form attached hereto as Annex A. In such event, each such Person shall thereafter shall be deemed an Investor for all purposes under this Agreement. 

Section 3.7 Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent
jurisdiction, the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or
unenforceable. 
 Section 3.8 Notices. All notices, requests, claims, demands and other communications hereunder shall be in
writing and shall be given (and shall be deemed to have been duly given) by delivery in person, by e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic record of the
sender that the e-mail was sent to the intended recipient thereof without an “error” or similar message that such e-mail was not received by such intended
recipient)), or by registered or certified mail (postage prepaid, return receipt requested) (upon receipt thereof) to the other parties as follows: 

If to PCPC: 
 Periphas
Capital Partnering Corporation 
 667 Madison Avenue, 15th Floor 

New York, New York 10065 

Attention:         Todd Nice 

E-mail:
             tnice@periphascap.com 
 with a copy (which will not constitute
notice) to: 
 Kirkland & Ellis LLP 

601 Lexington Avenue, 
 New York,
NY 10022 
 Attention:         Christian Nagler 

                        
 Wayne Williams 
 E-mail:
            Christian.Nagler@kirkland.com 

                        
 Wayne.Williams@kirkland.com 

  
 7 

 If to the Investor, to the address or facsimile number set forth for the Investor on the
signature page hereto. 
 Section 3.9 Counterparts. This Agreement may be executed in two or more counterparts (any of which may
be delivered by electronic transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument. 

Section 3.10 Entire Agreement. This Agreement and the agreements referenced herein constitute the entire agreement and
understanding of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by or among the parties hereto to the extent they relate in any way to the subject matter hereof. 

Section 3.11 Further Assurances. From time to time and without additional consideration, but at the sole cost and expense of PCPC,
the Investor shall execute and deliver, or cause to be executed and delivered, such additional transfers, assignments, endorsements, proxies, consents and other instruments, and shall take such further actions, as PCPC may reasonably request for the
purpose of carrying out and furthering the intent of this Agreement. 
 [Signature page follows] 

  
 8 

 IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed as of the
date first written above. 
  

			
	PCPC:
	
	PERIPHAS CAPITAL PARTNERING CORPORATION
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Investor Support Agreement] 

 
			
	INVESTOR:
	
	[•]
		
	By:	 	  

		 	Name:
		 	Title:
		
	Address:	 	_____________________________
		
		 	_____________________________
		
		 	_____________________________
	
	PCPC Shares owned: [•]
	
	PCPC Warrants owned: [•]

 [Exhibit A to Investor Support Agreement] 

 Exhibit A 

Form of Joinder Agreement 

The undersigned is executing and delivering this joinder agreement (this “Joinder”) pursuant to the Investor Support
Agreement, dated as of October 27, 2022 (as the same may hereafter be amended, the “Investor Support Agreement”), by and among Periphas Capital Partnering Corporation, a Delaware corporation, and the Investors thereto.
Capitalized terms used but not otherwise defined herein shall have the meanings provided in the Investor Support Agreement. 
 By executing
and delivering this Joinder, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the Investor Support Agreement as an Investor in the same manner as if the undersigned were an original signatory to the Investor
Support Agreement. For purposes of the Investor Support Agreement, the table below sets forth the name of the undersigned Investor, the number of PCPC Shares held by the Investor and the number of PCPC Warrants held by the Investor: 

 

					
	 Name of Investor
	  	 Number of PCPC Shares Beneficially Owned
	  	 PCPC Warrants Beneficially Owned

	[Name]	  	[ ]	  	[ ]

 Accordingly, the undersigned has executed and delivered this Joinder as of the date written below. 

 

							
	Date: [•], 2022	 		 		 	
				
		 		 	By:	 	  

		 		 		 	Name:
		 		 		 	Title:
			
		 		 	Address for Notices:
			
		 		 	With copies to:

 [Exhibit A to Investor Support Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]